Veradermics, Incorporated · NYSE:MANE
Averill Master Fund, Ltd. sold 750,000 Veradermics, Incorporated shares (Form 4)
Traded Aug 19 to Aug 20, 2026 · Filed Aug 21, 2026
From Aug 19 to Aug 20, 2026, Averill Master Fund, Ltd. (Director) sold 750,000 Veradermics, Incorporated shares at US$107.25 for US$80.4M, leaving 612,033 shares. Filed Aug 21, 2026 (Form 4).
- Sold
- 750,000 shares
- Price
- US$107.25
- Value
- US$80.4M
- Holding after
- 612,033 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common stock, par value $0.00001 per share | Sale | 690,601 | US$107.25 | 2,957,937 | Indirect |
| Aug 19, 2026 | Common stock, par value $0.00001 per share | Sale | 59,399 | US$107.25 | 461,033 | Indirect |
| Aug 20, 2026 | Common stock, par value $0.00001 per share | Option exercise | 149,000 | 3,106,937 | Indirect | |
| Aug 20, 2026 | Common stock, par value $0.00001 per share | Option exercise | 151,000 | 612,033 | Indirect |
Source
Related
- Veradermics, Incorporated
- Averill Master Fund, Ltd.
- Veradermics, Incorporated shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Hollander David · Sep 3, 2026
- Schedule 13D/A · Montanova Capital, LLC · Aug 21, 2026
- Form 4 · Durso Timothy August · Aug 18, 2026
- Form 4 · Waldman Reid Alexander · Aug 18, 2026